Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis
Marina S. Gelman, Ron R. Kopito
Marina S. Gelman, Ron R. Kopito
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1591-1597. https://doi.org/10.1172/JCI16786.
View: Text | PDF
Perspective Article has an altmetric score of 3

Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis

  • Text
  • PDF
Abstract

Perspective

Authors

Marina S. Gelman, Ron R. Kopito

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Biogenesis and intracellular trafficking pathway of wild-type (a) and ΔF...
Biogenesis and intracellular trafficking pathway of wild-type (a) and ΔF508 (b) CFTR. The width of the gray arrows is proportional to the relative flux through a particular branch of the pathway. Synthesis and cotranslational integration (step 1) in the ER membrane are followed by folding to a native conformation (step 2). About 25% of wild-type and more than 99% of ΔF508 CFTR molecules are degraded by a process that is mediated by cytoplasmic proteasomes (step 3). Native CFTR molecules (light blue cylinder) are delivered via the Golgi apparatus (not shown) to the plasma membrane (step 4), where they are subject to rapid endocytosis (step 5) to subapical vesicles (light blue lumen). CFTR is recycled to the plasma membrane (step 6), where it can be activated by cAMP-dependent kinases (step 7). Differences in the relative rates of recycling and degradation in lysosomes (pink lumen; step 8) are likely to account for the substantial differences in half-lives between wild-type and ΔF508 CFTR.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
29 readers on Mendeley
See more details